THE SAFETY OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN HIV POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY

THE SAFETY OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS IN HIV POSITIVE PATIENTS RECEIVING ANTIRETROVIRAL THERAPY

The review analyzed the studies and meta-analyses devoted the treatment of multiple drug resistant tuberculosis in combination with antiretroviral therapy as a possible risk factor of adverse events and the worst outcomes of therapy. In total, the analysis included 18 sources from the Russian and En...

Full description

Bibliographic Details
Main Authors:	S. Yu. Degtyareva, E. N. Beloborodova, A. V. Pokrovskaya, Yu. A. Klimova, I. B. Viktorova, V. N. Zimina
Format:	Article
Language:	Russian
Published:	NEW TERRA Publishing House 2019-04-01
Series:	Tuberkulez i Bolezni Lëgkih
Subjects:	antiretroviral therapy anti-tuberculosis therapy mdr tb/hiv infection adverse events
Online Access:	https://www.tibl-journal.com/jour/article/view/1252

Similar Items

Treatment efficacy and tuberculosis relapses in HIV infected patients with severe immunosuppression who started antiretroviral therapy
by: E. V. Korzh, et al.
Published: (2020-11-01)

Host-directed therapies for multidrug resistant tuberculosis
by: Alimuddin Zumla, et al.
Published: (2016-01-01)

Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy
by: Lili Dai, et al.
Published: (2020-02-01)

Factors associated with multidrug-resistant tuberculosis
by: Md Nurul Amin, et al.
Published: (2009-01-01)

Prevalence of Multi-Drug Resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa – A High Tuberculosis Endemic Area of Pakistan
by: SAJID ALI, et al.
Published: (2020-01-01)

Efficacy of antituberculosis therapy in combination with antiretroviral therapy in patients with co-infection TB/HIV
by: Kryzhanovsky D.G., et al.
Published: (2013-03-01)

Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
by: Kathryn Schnippel, et al.
Published: (2016-10-01)

Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania
by: M. Majigo, et al.
Published: (2020-09-01)

Knowledge, attittudes and practices of healthcare workers about prevention and control of multidrug-resistant tuberculosis at Botsabelo Hospital Maseru, Lesotho
by: Adebanjo, Omotayo David
Published: (2012)

Turning the tide against tuberculosis
by: Nesri Padayatchi, et al.
Published: (2017-03-01)

Tuberculous meningitis in patients with concurrent tuberculosis and HIV infection who have started antiretroviral therapy: the specific course and prognosis
by: E V. Korzh, et al.
Published: (2019-10-01)

Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques
by: Caylin G. Winchell, et al.
Published: (2020-05-01)

Plasma Levels of Cytokines (IL-10, IFN-γ and TNF-α) in Multidrug Resistant Tuberculosis and Drug Responsive Tuberculosis Patients in Ghana
by: Anthony Basingnaa, et al.
Published: (2018-12-01)

Perspectives on tuberculosis in pregnancy
by: Matthew Bates, et al.
Published: (2015-03-01)

Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: a Study of Indonesian National Tuberculosis Prevalence Survey
by: Rosalia Sri Sulistijawati, et al.
Published: (2019-04-01)

Multidrug resistant tuberculosis versus non-tuberculous mycobacterial infections: a CT-scan challenge
by: Shahram Kahkouee, et al.

Multidrug resistant tuberculosis versus non-tuberculous mycobacterial infections: a CT-scan challenge
by: Shahram Kahkouee, et al.
Published: (2013-04-01)

Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
by: Ivana Palucci, et al.
Published: (2020-01-01)

Phenotypic and genotypic variant of MDR-Mycobacterium tuberculosis multiple isolates in the same tuberculosis episode, Rio de Janeiro, Brazil
by: M.K.N. Andrade, et al.
Published: (2009-05-01)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019-07-01)

Factors associated to modification of first-line antiretroviral therapy due to adverse events in people living with HIV/AIDS
by: Larissa Negromonte Azevedo, et al.
Published: (2020-01-01)

High incidence of adverse reactions to initial antiretroviral therapy in Brazil
by: C.A. Menezes de Pádua, et al.
Published: (2006-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Relationship of Mutation of Kodon S 315 T katG Mycobaterium Tuberculosis Gene with Multidrug Resistance Tuberculosis in South Sumatera
by: Diah Syafriani, et al.
Published: (2020-05-01)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016-06-01)

Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda
by: Ngabonziza, J.-C.S., et al.
Published: (2020)

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities
by: S.E. McAnaw, et al.
Published: (2017-03-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

Trends in multidrug-resistant tuberculosis
by: I. M. F. Dias-Baptista, et al.
Published: (2008-01-01)

Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo
by: Michel Kaswa Kayomo, et al.
Published: (2018-11-01)

Management of multidrug resistant tuberculosis (MDR-TB) – Monitoring is the key to successful
by: J.S. Akshata, et al.
Published: (2016-04-01)

Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis
by: V N Zimina, et al.
Published: (2015-11-01)

Trends in multidrug-resistant tuberculosis in Tehran, Iran: an analysis of published data
by: Nasiri, Mohammad Javad, et al.
Published: (2019-08-01)

Multidrug Resistant Tuberculosis (MDR-TB): Tinjauan Epidemiologi dan Faktor Risiko Efek Samping Obat Anti Tuberkulosis
by: Reviono, et al.
Published: (2014-12-01)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
by: Cannas A, et al.
Published: (2019-10-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant Tuberculosis in Viet Nam
by: Minh Ha Dang, et al.
Published: (2012-03-01)

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
by: Jay Achar, et al.
Published: (2017-10-01)

First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon
by: Balig Panossian, et al.
Published: (2018-12-01)